Pimavanserin: A Novel Drug Approved to Treat Parkinson’s Disease Psychosis

Objective: Pimavanserin is the first United States Food and Drug Administration (FDA)-approved treatment for Parkinson’s disease psychosis (PDP). This article reviews the safety, efficacy, and pharmacology data for pimavanserin and its role in therapy. Method of Research: Initial literature sources...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Innov Clin Neurosci
Main Authors: Kitten, Amanda K., Hallowell, Sarah A., Saklad, Stephen R., Evoy, Kirk E.
Format: Artigo
Sprog:Inglês
Udgivet: Matrix Medical Communications 2018
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5819716/
https://ncbi.nlm.nih.gov/pubmed/29497575
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker